Neuroscience peer-review posse grows

Nature Neuroscience is joining an alliance of journals that share manuscript peer-reviews, according to the journal's April linkurl:editorial.;http://www.nature.com/neuro/journal/v11/n4/full/nn0408-375.html The linkurl:Neuroscience Peer Review Consortium;http://nprc.incf.org/ (NPRC) is a group of linkurl:neuroscience;http://www.the-scientist.com/2007/8/1/60/1/ journals that have agreed to accept reviews from other members of the Consortium in an effort to accelerate and improve the efficiency o

By | April 7, 2008

Nature Neuroscience is joining an alliance of journals that share manuscript peer-reviews, according to the journal's April linkurl:editorial.;http://www.nature.com/neuro/journal/v11/n4/full/nn0408-375.html The linkurl:Neuroscience Peer Review Consortium;http://nprc.incf.org/ (NPRC) is a group of linkurl:neuroscience;http://www.the-scientist.com/2007/8/1/60/1/ journals that have agreed to accept reviews from other members of the Consortium in an effort to accelerate and improve the efficiency of the publication process. Under the scheme, authors whose papers are rejected by one journal can choose to have the linkurl:reviews;http://www.the-scientist.com/article/display/23061/ forwarded to a second participating journal. The system is optional, but may be in the author's best interests, especially if the reviews are positive but suggest that the paper would be more suitable for a different journal. Referees for member journals, who will always remain anonymous to authors, must agree to allow their reviews to be shared between journals, but can decide whether or not to reveal their identities to editors once a review has been passed along. Nature Neuroscience — the top-ranking neurosciences primary research journal with an impact factor (IF) of 14.805, according to the 2006 ISI Journal Citation Reports — is the 28th journal to sign up to the NPRC, joining others including Journal of Neuroscience (IF = 7.453) and NeuroImage (IF = 5.559). The Consortium, which is supported by the linkurl:Society for Neuroscience,;http://www.sfn.org/ started at the beginning of the year and will run for a one-year trial period that ends December 31, 2008.

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham